Back to Journals » Infection and Drug Resistance » Volume 19

Amphotericin B Colloidal Dispersion is Efficacious and Safe for the Management of Talaromycosis in HIV-Infected Patients: Results of a Retrospective Cohort Study in China [Corrigendum]

Authors Liu M, Yang H, Liu Q, He K, Yuan J, Chen Y ORCID logo

Received 27 November 2025

Accepted for publication 27 November 2025

Published 30 May 2026 Volume 2026:19 584794

DOI https://doi.org/10.2147/IDR.S584794



Liu M, Yang H, Liu Q, He K, Yuan J, Chen Y. Infect Drug Resist. 2024;17:5581–5593.

The authors have advised that the funding statement on page 5591 is incorrect. The correct statement should read as follows.

FundingThis work was supported by the Chongqing Talent Cultivation Program (cstc2021ycjh-bgzxm0275), the Key Project of the Chongqing Science & Technology Bureau (cstc2020jscx-cylhX0001), Chongqing Medical Scientific Research project (joint project of Chongqing Health Commission and Science and Technology Bureau) 2024MSXM149, and the Chongqing Key Public Health Disciplines Improvement Project.

The authors apologize for this error.


Read the original article


Creative Commons License © 2026 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms and incorporate the Creative Commons Attribution - Non Commercial (unported, 4.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.